OTC · Medical - Diagnostics & Research

Global WholeHealth Partners Corporation (GWHP) Stock

$0.00 OTC: GWHP Healthcare

Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests.

Valuation

MetricValue
Price$0.00
Market Cap$1313
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.18
EPS (TTM)$-0.05
52-Week High$6.00
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE250.00%
ROA—
ROCE266.71%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity-0.50
Current Ratio0.01

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$0$0$-4.0M$-4.0M$-4.0M
Net Profit$0$0$-4.0M$-9.0M$-5.0M
EPS$-0.02$0.00$-0.07$-0.14$-0.05
Op Margin——-1765.5%-8926.3%-56759.3%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$1.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$1.0M

Latest News

Kirkland tops North America M&A table in H1 Private Banker International · Jul 30, 2026 Meta stock sinks 10% on earnings miss, 'barely passable' quarter Yahoo Finance · Jul 30, 2026 Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big GuruFocus.com · Jul 30, 2026 RBC Raises Price Target on General Dynamics to $410 From $385, Keeps Sector Perform Rating MT Newswires · Jul 30, 2026 Tourmaline Oil Q2 Earnings Fall 65% YoY MT Newswires · Jul 30, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$-1.0M$-1.0M$-2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.17
FCF Yield-149901.52%
Quick Ratio0.01
Interest Coverage-4.32
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EPRSQEPIRUS Biopharmaceuticals, Inc. $0.00 — — $1571 0.00%
GNRSThe Greenrose Holding Company Inc. $0.00 — 0.00 $1768 0.00%
MICRDMicron Solutions, Inc. $0.00 — 0.00 $317 0.00%
MLTOMEDirect Latino, Inc. $0.00 — — $1700 0.00%
MTEMMolecular Templates, Inc. $0.00 — 0.00 $658 0.00%

About Global WholeHealth Partners Corporation

Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests. These diagnostic tools are designed for wide accessibility, catering to both over-the-counter consumer purchases and professional point-of-care settings such as hospitals, physicians' offices, and various medical clinics. Their product line effectively identifies a multitude of diseases, encompassing infections like Ebola, Zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other conditions transmitted by vectors.

Global WholeHealth Partners Corporation (GWHP) stock trades at $0.00 with a market capitalization of $1313. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.18.

On profitability, Global WholeHealth Partners Corporation generates a return on equity (ROE) of 250.00% — well above the market average, a sign of a high-quality business, return on capital employed of 266.71%.

Official website: gwhpcorp.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides